Marshall Wace, LLP Applied Molecular Transport Inc. Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.63 - $13.88 $181,066 - $446,394	-32,161 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.23 - $26.05 $273,053 - $537,645	20,639 Added 179.13%	32,161 $450,000
Q3 2021 Nov 15, 2021	BUY	$25.87 - $46.61 $79,705 - $143,605	3,081 Added 36.5%	11,522 $298,000
Q2 2021 Aug 13, 2021	BUY	$39.76 - $64.31 $335,614 - $542,840	8,441 New	8,441 $386,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.